Editas Medicine
EDIT
EDIT
256 hedge funds and large institutions have $561M invested in Editas Medicine in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 74 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less call options, than puts
Call options by funds: $19.9M | Put options by funds: $20.8M
35% less capital invested
Capital invested by funds: $862M → $561M (-$301M)
Holders
256
Holding in Top 10
–
Calls
$19.9M
Puts
$20.8M
Top Buyers
| 1 | +$28.4M | |
| 2 | +$11.8M | |
| 3 | +$7.96M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$7.45M |
| 5 |
BlackRock
New York
|
+$5.31M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$7.06M | |
| 3 | -$6.41M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$6.19M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.44M |